58. 肥大型心筋症 Hypertrophic cardiomyopathy Clinical trials / Disease details

臨床試験数 : 126 / 薬物数 : 135 - (DrugBank : 42) / 標的遺伝子数 : 46 - 標的パスウェイ数 : 162

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01556568 (ClinicalTrials.gov)	February 2012	15/3/2012	Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162in Noonan Syndrome Hypertrophic ...	An Open Label Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162i ...	Cardiomegaly	Drug: MEK162	Array Biopharma, now a wholly owned subsidiary of Pfizer	NULL	Withdrawn	18 Years	65 Years	All	0	Phase 2	United States;United Kingdom
2	EUCTR2011-003392-10-GB (EUCTR)	23/01/2012	24/08/2011	A study to look at the effect of the study drug on heart muscle thickness, the amount of drug that e ...	An open label study to assess safety, tolerability, pharmacokinetics and pharmacodynamics of MEK162i ...	Noonan syndrome hypertrophic cardiomyopathy MedDRA version: 14.1;Level: PT;Classification code 10029 ...	Product Code: MEK162	Novartis Pharma Services AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	22		United Kingdom;United States

First Previous1Next Last